Trials
Search / Trial NCT00001137

Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

Launched by ADVANCING CLINICAL THERAPEUTICS GLOBALLY FOR HIV/AIDS AND OTHER INFECTIONS · Aug 30, 2001

Trial Information

Current as of January 15, 2025

Completed

Keywords

Treatment Experienced Treatment Naive Virus Replication Aids Related Opportunistic Infections Hiv 1 Risk Factors Incidence Rna, Viral Anti Hiv Agents Viral Load Lipodystrophy Nervous System Cardiovascular System Neurologic Symptoms

ClinConnect Summary

A compilation of outcomes of various antiretroviral therapies would be beneficial when evaluating which strategies are most effective in long-term treatment of HIV-1. Using data from present and recently completed studies, this study will collect information on therapies and their control of HIV infection and maintenance of durable suppression of HIV-1 replication.

No treatment is provided by this study, but patients will continue to receive highly active antiretroviral therapy (HAART) from other studies in which they are coenrolled. Blood and urine collection will occur at study entry and...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria
  • HIV-1 infected
  • Enrolled in an AIDS Clinical Trial Group (ACTG) parent study and has enrolled in this study on or before the Week 16 visit of the parent study, including the visit window of the parent study. More information on this criterion can be found in the protocol.
  • Willing to provide consent for the release and use of clinical data from the parent study
  • Life expectancy of at least 24 weeks
  • Parent or guardian willing to provide informed consent, if applicable
  • Exclusion Criteria
  • Active alcohol or drug abuse that may interfere with the study

Trial Officials

Constance A. Benson, MD

Study Chair

Division of Infectious Disease, Antiviral Research Center, University of California, San Diego

Ann C. Collier, MD

Study Chair

University of Washington

About Advancing Clinical Therapeutics Globally For Hiv/Aids And Other Infections

Advancing Clinical Therapeutics (ACT) is a global clinical trial sponsor dedicated to the development and advancement of innovative therapies for HIV/AIDS and other infectious diseases. With a commitment to improving patient outcomes, ACT conducts rigorous clinical research that adheres to the highest ethical standards and regulatory guidelines. Our multidisciplinary team collaborates with healthcare professionals, researchers, and stakeholders worldwide to facilitate the discovery and validation of effective treatments, aiming to enhance the quality of life for individuals affected by these conditions. Through our efforts, we strive to contribute significantly to the global fight against infectious diseases, fostering a healthier future for communities around the world.

Locations

New York, New York, United States

Birmingham, Alabama, United States

Los Angeles, California, United States

Indianapolis, Indiana, United States

Indianapolis, Indiana, United States

New York, New York, United States

New York, New York, United States

New York, New York, United States

Columbus, Ohio, United States

West Columbia, South Carolina, United States

Chicago, Illinois, United States

Chicago, Illinois, United States

San Diego, California, United States

Chicago, Illinois, United States

New York, New York, United States

New York, New York, United States

Rochester, New York, United States

Chapel Hill, North Carolina, United States

San Jose, California, United States

Stanford, California, United States

Stanford, California, United States

Torrance, California, United States

Washington, District Of Columbia, United States

Miami, Florida, United States

Honolulu, Hawaii, United States

Boston, Massachusetts, United States

Omaha, Nebraska, United States

Buffalo, New York, United States

Greensboro, North Carolina, United States

Cincinnati, Ohio, United States

Cleveland, Ohio, United States

Philadelphia, Pennsylvania, United States

San Juan, , Puerto Rico

Charlotte, North Carolina, United States

Los Angeles, California, United States

Durham, North Carolina, United States

Pittsburgh, Pennsylvania, United States

Minneapolis, Minnesota, United States

Denver, Colorado, United States

Boston, Massachusetts, United States

Boston, Massachusetts, United States

St Louis, Missouri, United States

Boston, Massachusetts, United States

Baltimore, Maryland, United States

Iowa City, Iowa, United States

New Orleans, Louisiana, United States

Atlanta, Georgia, United States

Atlanta, Georgia, United States

Indianapolis, Indiana, United States

Nashville, Tennessee, United States

Los Angeles, California, United States

Menlo Park, California, United States

San Rafael, California, United States

New York, New York, United States

New York, New York, United States

Seattle, Washington, United States

Rochester, New York, United States

Dallas, Texas, United States

Tripler Amc, Hawaii, United States

Denver, Colorado, United States

Camden, New Jersey, United States

Bronx, New York, United States

Portland, Oregon, United States

Houston, Texas, United States

Sacramento, California, United States

San Francisco, California, United States

Baltimore, Maryland, United States

Detroit, Michigan, United States

Minneapolis, Minnesota, United States

Newark, New Jersey, United States

Rochester,, New York, United States

Chapel Hill, North Carolina, United States

Cleveland, Ohio, United States

Norristown, Pennsylvania, United States

Dallas, Texas, United States

Richmond, Virginia, United States

San Juan,, , Puerto Rico

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials